Eccleston-Turner, MR (2017) The Pandemic Influenza Preparedness Framework: a viable procurement option for developing states? Medical Law International, 17 (4). pp. 227-248. ISSN 0968-5332

This is the latest version of this item.

[thumbnail of Main-Text----PIPF.pdf]

Download (276kB) | Preview


In this article, I argue that the Pandemic Influenza Preparedness (PIP) Framework is unlikely to have a significant impact on procurement of pandemic influenza vaccines by developing states during the next pandemic. I argue this on the basis that the vaccine stockpile that the Framework has created is not sufficiently large to meet the demand from developing states. I also argue that the fact that so few pandemic influenza vaccine manufacturers have committed to supply the PIP stockpile, and those that have, have given commitments lower than those initially proposed by the World Health Organization in the Framework, implies that the overall impact the PIP stockpile will have on procurement of pandemic influenza vaccines is even lower than initially anticipated within the literature.


Item Type: Article
Additional Information: This is the accepted author manuscript (AAM). The final published version (version of record) is available online via Sage Publications at - please refer to any applicable terms of use of the publisher.
Uncontrolled Keywords: Access to medicine, pandemic influenza, pip framework, transfer of technology, H1N1
Subjects: K Law > K Law (General)
R Medicine > R Medicine (General)
Divisions: Faculty of Humanities and Social Sciences > School of Law
Depositing User: Symplectic
Date Deposited: 25 Aug 2017 09:01
Last Modified: 11 Feb 2021 10:26

Available Versions of this Item

Actions (login required)

View Item
View Item